Rapid Diagnostics

Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America | PR Newswire | 7/29/2020

… co-founder and CEO John Kelly said, “This is an exciting development for Atomo, and we are proud to be partnering with Access Bio on this project. Access Bio is a leading manufacturer in rapid diagnostics , with strong ties to US markets and as a long-standing trusted partner of Atomo having existing partnerships for HIV and Hepatitis C, is a natural fit for the next phase of our expansion …

HR Generalist I | 7/28/2020

HR Generalist I from Staffing the Universe Westbrook, ME About the Job The position of HR Generalist is within our Client Rapid Diagnostics Business located at Scarborough, Maine. This role will help organize, coordinate and carry out all human resource department projects and processes for the site.This job description will be reviewed periodically and is subject to change by management.RESPONSIBILITIES: Ensures all employee records are filed correctly and kept confidential …

Follow Rapid Diagnostics:    

Production Specialist II (Nights) | 7/28/2020

Shift Days will be determined upon start but the schedule is: Sunday - Wednesday or Wednesday-SaturdayHours: 4:45pm-5:15amClient Rapid Diagnostics is part of Client’s Diagnostics family of businesses, bringing together exceptional teams of experts and industry leading technologies to support diagnostic testing which provides important information for treatment and management of diseases and other conditions.The position of Production Specialist II is within our Infectious Disease Developed Markets business unit located …

How Israeli scientists are improving corona testing | 7/27/2020

… of samples in 10 days and analyze them using a “voice print” analysis technology from Vocalis , a breathalyzer test from the Tera Group , an isothermal test from Kidod, and a polyamino acid test from Rapid Diagnostics . Below are details on a range of proposed Israeli testing solutions. Rapid no-lab test kit Rambam Health Care’s research collaboration with the nearby Technion-Israel Institute of Technology is yielding a variety of …

The Global infectious disease rapid diagnostics testing market emerge the market growth owing to cost-effective diagnosis device and prevalence of chronic diseases | 7/26/2020

The Global infectious disease rapid diagnostics testing market will fuel CAGR in the forecast period from 2020-2027. The prevalence of contagious diseases spreading through pathogens, viruses, and microorganisms coupled with chronic conditions, has emerged the market demand for the global infectious disease rapid diagnostics testing market. The rapid diagnosis kits market demand emerging due to the rising diseases such as cancer, diabetics, HIV, as well pregnancy kits also contributed to …

COVID-19: RDT test kits are illegal – Lagos State Government | 7/24/2020

1 The Lagos state government has warned against patronizing unauthorized health facilities and the use of Rapid Diagnostics Test Kits for COVID19 testing in Lagos. Speaking at a news briefing with journalists on the COVID-19 situation in Lagos, the Commissioner for Health, Professor Akin Abayomi said the use of Rapid Diagnostics Test kits remains illegal until it is validated. Abayomi stated that RDT kits have a very high risk …

Coronavirus Tests: Why Demand Won’t Wane Even If There’s An Effective Covid-19 Vaccine | Investor’s Business Daily | 7/24/2020

… floor on (per-share earnings) given the uncertainty around second wave (of Covid-19) and medtech procedure volume trends,” Evercore ISI analyst Vijay Kumar said in a recent report to clients. In addition, Abbott’s rapid diagnostics business grew 11% organically and brought in $180 million in coronavirus test sales. That included the company’s rapid point-of-care test for Covid-19. Coronavirus test demand generated nearly 34% of that segment’s …

Respiratory Infectious Disease Diagnostics Market to Reflect Impressive Growth Rate by 2030 | 7/24/2020

… the demand for diagnosis during forecast period. As per current statistics, in April 2020, 6.08 million people across globe were infected with COVID 19 diseases, and this is likely to impact the need for rapid diagnostics testing. is likely to boost the respiratory infectious diagnostics market during forecast period. Key Drivers and Restraints of Global Respiratory Infectious Disease Diagnostics Market Rise in prevalence of respiratory infectious diseases, such as Coronavirus …

Production Specialist II (Days) | 7/23/2020

Shift Days will be determined upon start but the schedule is: Sunday - Wednesday or Wednesday-SaturdayHours: 4:45am-5:15pmClient Rapid Diagnostics is part of Clients Diagnostics family of businesses, bringing together exceptional teams of experts and industry leading technologies to support diagnostic testing which provides important information for treatment and management of diseases and other conditions.The position of Production Specialist II is within our Infectious Disease Developed Markets business unit located …

QA/QC Technician I | 7/23/2020

Daily Schedule/Hours: 7:30am-4pm (40hrs/wk)DescriptionClient Rapid Diagnostics is part of Client’s Diagnostics family of businesses, bringing together exceptional teams of experts and industry leading technologies to support diagnostic testing which provides important information for treatment and management of diseases and other conditions.The position of Quality Control Technician is within our Infectious Disease Developed Markets business unit located at Scarborough, Maine. In this role you will perform work …

USAID Hands Over US$1.7M Medicines to GoL | 7/20/2020

… presented by Chargé d’Affaires Grunder are in addition to other much needed medical commodities the United States has provided the people of Liberia for several years now. USAID currently procures all of the malaria rapid diagnostics tests for the public sector, and a significant percentage of all malaria treatments for adults and children, as well as half of all family planning commodities used in government owned or operated health facilities …

Asia Pacific In Vitro Diagnostics Market Emerging Trends and Business Opportunities | 7/17/2020

… of infectious and chronic diseases, rising awareness regarding advanced diagnostics solutions as well as technological advancements are expected to boost the in vitro diagnostic market in the Asia Pacific region. The increasing need for rapid diagnostics , rise in healthcare spending, and rapid adoption of advanced technologies in the countries like India and China attributes to the escalating growth rate of the in vitro diagnostics in the region. Moreover, the increasing …

Abbott Reports Second-Quarter 2020 Results, Exceeds Analysts’ Expectations | PR Newswire | 7/16/2020

… percent on an organic basis in the second quarter. Lower base business sales were more than offset by strong demand for Abbott’s point-of-care COVID-19 molecular test on its ID NOW ™ platform. Rapid Diagnostics COVID-19 testing-related sales were $180 million in the quarter. Established Pharmaceuticals ($ in millions) % Change vs. 2Q19 Sales 2Q20 Reported Organic U.S. Int’l Total U.S. Int’l Total U.S. Int’l Total Total – 1,013 1,013 …

Demand For Abbott Labs Covid-19 Tests Surges Past 40M As Pandemic Lingers | Forbes | 7/16/2020

… quarter. Of that, molecular diagnostics Covid-19 testing-related sales were $283 million in the quarter, the company said as hospitals and laboratories added coronavirus tests on Abbott’s m2000TM and AlinityTM m platforms. Meanwhile, rapid diagnostics sales rose nearly 10% to $530 million thanks to strong demand for Abbott’s “point-of-care” Covid-19 molecular test on the company’s ID NOWTM platform. “Rapid Diagnostics COVID-19 testing-related sales were …

Abbott (ABT) Q2 Earnings Top, Coronavirus Test Sales Solid - July 16, 2020 - Zacks.com | 7/16/2020

… the detection of the IgG antibody. Molecular Diagnostics surged 241.4% on an organic basis on solid demand for Abbott’s laboratory-based molecular tests for COVID-19 on its m 2000 and Alinity m platforms. Rapid Diagnostics sales too improved 11% on an organic basis in the June-end quarter. However, Point of Care Diagnostics sales declined 17.6% on an organic basis. 2020 Guidance The company issued a fresh guidance for …

#EndTB Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment | 7/14/2020

A special EndTB Webinar was organized by the World Health Organization (WHO) on 9 July 2020 toprovide key updates on recently released new WHO guidance on rapid diagnostics and drug-resistant TB treatment. The aim of the webinar was to facilitate a better understanding of the guidance to enable its rapid uptake in countries by national programmes and other key stakeholders. This will translate to earlier access to quality diagnosis …

COVID-19 Outbreak-Global Point-of-Care or Rapid Diagnostics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020 | 7/14/2020

COVID-19 Outbreak-Global Point-of-Care or Rapid Diagnostics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020 The Point-of-Care or Rapid Diagnostics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export …

OPKO Health’s BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees | PR Newswire | 7/13/2020

… players and referees, as well as team and league staff participating in the NBA’s season restart in Orlando . Under the agreement with the NBA, BioReference will provide COVID-19 testing, which includes PCR diagnostics, rapid diagnostics and antibody testing. The NBA and BioReference collaborated on testing protocols to provide the safest possible environment to restart the 2019-20 NBA season, going to extraordinary lengths to understand both the threats of the …

Abbott Laboratories Urged to Understand Africa’s Needs With Covid-19 | 7/13/2020

… pandemic. Noting that Abbott Laboratories miscalculated the situation believing that they were dealing with the old Africa where there would be no consequences for their reprehensible actions. Bassem Bibi, Vice President & General Manager, Abbott Rapid Diagnostics EM Africa According to a statement from Centurion Law Group, the law firm that decided to take on this matter against Abbott laboratories, “we knew the classic misrepresentation and bullying will come”. The law …

Instructor, Department of Medicine - School of Medicine | 7/10/2020

… fellowship experience (5+ years) in Biomedical Engineering or related disciplines. Of particular interest are candidates with experience in the development and translation of micro and nano systems-engineered technologies for point-of-care testing, rapid diagnostics , gene therapy and precision engineering. (S)he is expected to develop highly innovative and commercially competitive systems and technologies that can be applied to unmet clinical needs in different research areas including infectious disease …

Uncovering the Unknowns to COVID-19 Testing | 7/9/2020

Uncovering the Unknowns to COVID-19 Testing Uncovering the Unknowns to COVID-19 Testing Wednesday, July 8, 2020 New test may improve COVID-19 diagnosis By Alexis Kessenich Many unknowns remain with the novel coronavirus, including diagnostic testing. Some tests have reported a false negative rate as high as 40%, incorrectly informing patients that they do not have a SAR-CoV-2 infection – the virus that causes COVID-19 – when …

12-15 Molecular Diagnostics Announces Its Point Of Care Product For Potential Test For Viral Infection | PRWeb | 7/6/2020

… and students for potential infection. EAST HAVEN, Conn (PRWEB) July 06, 2020 12-15 Molecular Diagnostics, a point of care diagnostic start up based in East Haven, Connecticut announces today that it has developed a rapid diagnostics test device which can distinguish between viral and bacterial infection using biofluids including saliva. The lab test with synthetic virus shows promising results with high specificity and sensitivity which are comparable to the lab …

Hepatitis Test Solution/Diagnosis Market worth $3.37 billion by 2023 | 7/6/2020

… factors driving this market. The ELISA segment is expected to hold the largest market share during the forecast period On the basis of technology, the hepatitis test solution/diagnosis market is segmented into ELISA, rapid diagnostics test, PCR, INAAT, and other technologies. In 2018, the ELISA is expected to account for the largest market share, by technology. The wide acceptance of this test in clinical practices to diagnose hepatitis is …

Factors influencing diagnosis and treatment initiation for multidrug-resistant/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review | BMJ | 7/3/2020

… diverse knowledge base about obstacles to DR-TB care in SSA to create a consolidated understanding to inform practice. It highlighted several health system and patient barriers. Our key findings include the role of rapid diagnostics and laboratory operational issues play in facilitating or impeding access. Rapid diagnostic tools, particularly Xpert, play a central role in accessing DR-TB diagnosis and treatment, and their absence would constitute a significant barrier …

Google Alert - nova | 7/3/2020

nova As-it-happens update ⋅ July 3, 2020 NEWS POC Diagnostics Market Overview 2020-2025 Abbott , Roche (Switzerland) and Siemens … Apsters News Other leading players who operate this rapid diagnostics market include Nova , PTS Diagnostics , Quidel , Chembio Diagnostics , Instrumentation … Flag as irrelevant Takeout at the Shore delivers big flavors without the crowds The Philadelphia Inquirer His smoke only amplifies the natural Jersey sweetness of big Cape May scallops. The Water Dog …

COVID-19

Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America | PR Newswire | 7/29/2020

… rapid diagnostic test ( RDT ) devices to Access Bio for use with its rapid test strip for detection of antibodies to COVID-19. Finished products being commercialised under this agreement include a COVID-19 rapid antibody … on this project. Access Bio is a leading manufacturer in rapid diagnostics, with strong ties to US markets and as a long-standing trusted partner of Atomo having existing partnerships for HIV and Hepatitis C …

CDC

Demand For Abbott Labs Covid-19 Tests Surges Past 40M As Pandemic Lingers | Forbes | 7/16/2020

CDC Director: It’s Time For Universal Masking To End Covid-19 Pandemic The huge jump in sales of diagnostics helped Abbott beat Wall Street’s earnings expectations given the pandemic and a related slowdown in healthcare … coronavirus tests on Abbott’s m2000TM and AlinityTM m platforms. Meanwhile, rapid diagnostics sales rose nearly 10% to $530 million thanks to strong demand for Abbott’s “point-of-care” Covid-19 molecular test on the company’s …

Molecular Diagnostics

12-15 Molecular Diagnostics Announces Its Point Of Care Product For Potential Test For Viral Infection | PRWeb | 7/6/2020

12-15 Molecular Diagnostics Announces Its Point Of Care Product For Potential Test For Viral Infection Share Article The company announces its Point of Care product which can distinguish between viral and bacterial infection using biofluids … East Haven, Connecticut announces today that it has developed a rapid diagnostics test device which can distinguish between viral and bacterial infection using biofluids including saliva. The lab test with synthetic virus shows promising results …

Digital Health

Cue Health nabbed $100 million in funding to validate its at-home molecular testing platform | Business Insider | 6/12/2020

This story was delivered to Insider Intelligence Digital Health Briefing subscribers earlier this morning. Insider Intelligence publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can learn more about subscribing here. The rapid diagnostics startup closed a $100 million Series C funding round to validate the use of its Cue Health Monitoring System as an FDA-approved at-home influenza testing …

Biotech

The global market for infectious disease rapid diagnostic testing is predicted to grow at a CAGR of 12.36% over the forecast period of 2020-2025 | PR Newswire | 6/10/2020

… Biotech, Quidel Corporation, Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton, Dickinson and Company, and Cellex Inc. Key Questions Answered: • What are the major market drivers, challenges, and opportunities in the global infectious disease rapid diagnostics testing market? • What are the underlying structures resulting in the emerging trends within the infectious disease diagnostic assays and systems? • What was the market value of the leading segments of the global infectious …

Food and Drug Administration

Abbott pushes back on study of coronavirus-test accuracy, false negatives - Business Insider | 5/19/2020

… of positive samples, depending on the collection method. The report instantly made headlines and prompted a warning from the US Food and Drug Administration. Abbott has major issues with the way the NYU researchers evaluated … totally inadequate,” Philip Ginsburg, a senior medical director for Abbott’s rapid diagnostics wing, said in an interview with Business Insider. It used “a skewed sample and not good science,” he said. The team of researchers …

Antibiotic Stewardship

The Missing Link in Fighting Antibiotic Resistance | 12/4/2019

The Missing Link in Fighting Antibiotic Resistance Rapid diagnostics can flag outbreaks of “superbugs” before they spread Methicillin-resistant Staphylococcus aureus (MRSA) bacteria. Credit: Janice Hainey Carr, Centers for Disease Control and Prevention Advertisement As … recently reported that the number of hospitals complying with its antibiotic stewardship program has doubled since 2014 . More time and money is being spent on researching new antibiotics . Nonprofit entities are getting involved in the …

National Institutes of Health

CARB-X funds VenatoRx Pharmaceuticals to support the development of a new class of oral antibiotics to treat multi-drug-resistant gonorrhea | BioSpace | 11/26/2019

… global superbug crisis CARB-X is investing up to $500 million between 2016-2021 to support the development of new antibiotics, rapid diagnostics, vaccines and other life-saving products. The goal is to support projects through … of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH). CARB-X is headquartered at Boston University School of Law. https://carb-x.org . Follow us on Twitter @CARB_X. About …

Clinical Data

Treatment Options for Carbapenem-resistant Gram- negative Bacterial Infections | 11/22/2019

… stewardship will become crucial in ensuring appropriate and rationale use of these new agents. Keywords. antimicrobial stewardship; carbapenemase; multidrug resistance; rapid diagnostics.                               As the antimicrobial resistance crisis worsens, carbapenem resist- ance in gram-negative pathogens … by some clinicians for severe infections such as VAP, but clinical data are limited and many patients cannot tolerate the gastrointestinal side effects [38]. As with colistin, tigecycline is mostly used in combination regi- mens …

Antimicrobial Stewardship

Treatment Options for Carbapenem-resistant Gram- negative Bacterial Infections | 11/22/2019

antimicrobial stewardship will become crucial in ensuring appropriate and rationale use of these new agents. Keywords. antimicrobial stewardship; carbapenemase; multidrug resistance; rapid diagnostics.                               As the antimicrobial resistance crisis worsens, carbapenem resist- ance in gram-negative pathogens poses a special clinical challenge, as carbapenems have long been considered the most active and potent agents against multidrug-resistant (MDR) gram-negative pathogens. Indeed, on the global priority list of antibiotic-resistant bacteria …

Department of Health and Human Services

T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel Nasdaq:TTOO | Globe Newswire | 11/20/2019

… resistance markers directly from whole blood—in three to five hours. “Fighting antimicrobial resistance not only requires the development of rapid diagnostics, like the T2Resistance Panel, but also requires access to these innovations so they … and does not necessarily represent the official views of the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, other funders, or CARB-X. Media Contacts: CARB-X: Jennifer …

NIH

T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel Nasdaq:TTOO | Globe Newswire | 11/20/2019

… resistance markers directly from whole blood—in three to five hours. “Fighting antimicrobial resistance not only requires the development of rapid diagnostics, like the T2Resistance Panel, but also requires access to these innovations so they … Diseases (NIAID), part of the US National Institutes of Health (NIH). CARB-X is investing up to $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines, and rapid diagnostics. CARB-X supports …

Medical Research

T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel Nasdaq:TTOO | Globe Newswire | 11/20/2019

… resistance markers directly from whole blood—in three to five hours. “Fighting antimicrobial resistance not only requires the development of rapid diagnostics, like the T2Resistance Panel, but also requires access to these innovations so they … US federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. NIAID conducts and supports research — at NIH, throughout the …

Diagnostic Tests

ASP Scan (Weekly) for Nov 15, 2019 | 11/18/2019

… an initial $6 million over 14 months to Inflammatix, of Burlingame, California, for developing three point-of-care host-response diagnostic tests to distinguish viral infections from bacterial ones, HHS said in a news release … a bacterium is crucial in knowing whether antibiotics are needed. “Rapid diagnostics are a cornerstone of our strategy to protect Americans from many bacterial and viral infections; earlier diagnosis can empower patients to take action …

Biotechnology Innovation Organization

With Few New Drugs To Treat Antibiotic Resistance, How Best To Deploy Them? | 11/13/2019

… sales were nowhere enough to recoup just their operating costs, let alone their investment expenditures,” says Greg Frank at the Biotechnology Innovation Organization , an industry group. “And we’ve seen that time and time again with … are looking for new drugs or new drug targets, or rapid diagnostics” — tests that can quickly help doctors identify the best antibiotic for a given infection, he says. “And all that is important work, but …

Penn State University

With Few New Drugs To Treat Antibiotic Resistance, How Best To Deploy Them? | 11/13/2019

… Penn State University, argues that there must be a better way to fight these superbugs other than engaging in an endless arms race with them. “Most people are looking for new drugs or new drug targets, or rapid diagnostics” — tests that can quickly help doctors identify the best antibiotic for a given infection, he says. “And all that is important work, but the heart of the problem is the evolutionary …

Blood Diagnostics

T2 Biosystems to Share Early Data at the World Anti-Microbial Resistance Congress (November 7-8, 2019) | Globe Newswire | 11/7/2019

… blood Diagnostics in Enabling Changes in Clinical Decisions and Improving Outcomes,” on November 8 at 9:25 a.m. “Antimicrobial resistance is no longer an emerging threat – it is a very real, clear and present danger to public health, making it important for professionals in the infectious disease industry to seriously consider all types of solutions to this issue. These solutions include, among others, rapid diagnostics of bloodstream infections and rapid resistance …

Biosensors

An aptasensor for the detection of Mycobacterium tuberculosis secreted immunogenic protein MPT64 in clinical samples towards tuberculosis detection | Nature | 11/7/2019

… intensified research are the priority targets of the end TB Strategy 2030 by World Health Organization (WHO) in fields of rapid diagnostics for the use at the point of care 1 . Current TB diagnostics tests … portable potentiostat. EIS is the technique used in impedimetric electrochemical biosensors. As compared to other biosensors, the impedimetric technique provides low cost, low power, scalable, and highly sensitive and label-free measurement with minimal hardware …

Centers for Medicare and Medicaid Services

Fighting antimicrobial resistance requires new diagnostic tools - STAT | 10/24/2019

rapid diagnostics to combat the impending resistance crisis, the U.S. government has taken three important steps in the last decade to create incentives for developing new, transformative technologies: creating Medicare payment incentives, developing a sample bank of resistant organisms, and directly funding innovation in the space. The Centers for Medicare and Medicaid Services has now mandated nationwide antimicrobial stewardship programs in all U.S. hospitals. CMS has further restructured payments for …

Point of Care Diagnostics

Abbott Reports Third-Quarter 2019 Results | PR Newswire | 10/16/2019

… 76 111 (6.6) (8.3) (7.8) (6.6) (6.3) (6.4) Point of Care 112 32 144 7.0 4.1 6.3 7.0 5.6 6.7 Rapid Diagnostics 283 194 477 3.6 (6.4) (0.7) 3.6 (2.8) 0.8 % Change vs. 9M18 Sales … negatively impacted by lower non-governmental organization purchases in Africa . Point of Care Diagnostics sales increased 6.3 percent on a reported basis in the third quarter, including an unfavorable 0.4 percent effect of foreign exchange …

Infection Prevention

FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens | PR Newswire | 10/10/2019

… and dignified burials. This marketing authorization may provide additional assurances to health care professionals seeking to use these types of rapid diagnostics. The ability to use this test to promptly make a presumptive Ebola diagnosis … vaccination campaigns, monitoring for symptoms, diagnostic testing, and implementation of infection prevention and control measures, such as safe and dignified burial procedures. During the 2014 outbreak, the Secretary of the Department of Health and Human …

Human Microbiome

Infectious Disease Research and Treatment in the Genomics Era | 10/3/2019

… human microbiome, rapid diagnostics, curing HIV, and NIH’s All of Us initiative. Within about 15 years, the human microbiome has gone from a distant curiosity to a fundamentally important contributor to health (and disease). It is still a bit of a black box, since many of the organisms cannot yet be cultured. But they can be sequenced, which may allow an understanding of the microbiome in times of good health …

Precision Medicine

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses | Benzinga | 9/4/2019

… the Netherlands, and Holzgerlingen, Germany, 04 September 2019, 0800 am CET, 0655 am ET - OpGen, Inc. (NASDAQ: OPGN , “ OpGen “)), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious … initial two main focuses for the company will be (a) rapid diagnostics for lower respiratory infection and urinary tract infection and (b) bioinformatics and NGS services for AMR prediction by Ares Genetics as well as …

Bioinformatics Services

Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses | Benzinga | 9/4/2019

rapid diagnostics for lower respiratory infection and urinary tract infection and (b) bioinformatics and NGS services for AMR prediction by Ares Genetics as well as bioinformatics services based on the Acuitas Lighthouse® AMR kowledgebase by OpGen. Key elements of the combined company’s strategy include: continuing to gain regulatory clearances and approvals and establish a market position for proprietary molecular diagnostic tests and platforms, capitalize on unique technology platforms, leverage global …

Biomarkers Testing

$16.2Bn Cardiac Biomarkers Testing Market by 2025 - Rising Demand for Efficient & Rapid Diagnostics of Cardiovascular Diseases | PR Newswire | 7/13/2019

Biomarkers Testing Market (2019-2025)” report has been added to ResearchAndMarkets.com’s offering. The Global Cardiac Biomarkers Testing Market size is expected to reach $16.2 billion by 2025, rising at a market growth of 11.4% CAGR during the forecast period. The recent product launches and further developments in the products are major growth trends which are providing lucrative growth opportunities to the cardiac biomarker market. The rising demand for efficient and rapid …

Abbott Laboratories

Abbott (ABT) Q2 Earnings Top, Coronavirus Test Sales Solid - July 16, 2020 - Zacks.com | 7/16/2020

Abbott Laboratories ( ABT - Free Report ) reported second-quarter 2020 adjusted earnings from continuing operations of 57 cents per share, exceeding the Zacks Consensus Estimate by 32.6%. However, the adjusted figure declined 30.5% from the prior … COVID-19 on its m 2000 and Alinity m platforms. Rapid Diagnostics sales too improved 11% on an organic basis in the June-end quarter. However, Point of Care Diagnostics sales declined 17.6% on an …

Cue Health

Cue Health nabbed $100 million in funding to validate its at-home molecular testing platform | Business Insider | 6/12/2020

This story was delivered to Insider Intelligence Digital Health Briefing subscribers earlier this morning. Insider Intelligence publishes hundreds of insights, charts, and forecasts on the Digital Health industry with the Digital Health Briefing. You can learn more about subscribing here. The rapid diagnostics startup closed a $100 million Series C funding round to validate the use of its Cue Health Monitoring System as an FDA-approved at-home influenza testing …

Quidel

Quidel Receives Amended Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay Using Sofia 1 Instrument | Business Wire | 6/10/2020

Quidel Receives Amended Emergency Authorization for Rapid Antigen COVID-19 Diagnostic Assay Using Sofia 1 Instrument Sofia® SARS Antigen FIA Point-of-Care test offers positive results in 15 minutes June 09, 2020 07:00 PM Eastern Daylight Time SAN DIEGO–( BUSINESS WIRE )– Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel has received an amended …

Thermo Fisher

The global market for infectious disease rapid diagnostic testing is predicted to grow at a CAGR of 12.36% over the forecast period of 2020-2025 | PR Newswire | 6/10/2020

Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton, Dickinson and Company, and Cellex Inc. Key Questions Answered: • What are the major market drivers, challenges, and opportunities in the global infectious disease rapid diagnostics testing market? • What are the underlying structures resulting in the emerging trends within the infectious disease diagnostic assays and systems? • What was the market value of the leading segments of the global infectious disease rapid diagnostics

Thermo Fisher Scientific

The global market for infectious disease rapid diagnostic testing is predicted to grow at a CAGR of 12.36% over the forecast period of 2020-2025 | PR Newswire | 6/10/2020

Thermo Fisher Scientific Inc., GenMark Diagnostics, CTK Biotech, Becton, Dickinson and Company, and Cellex Inc. Key Questions Answered: • What are the major market drivers, challenges, and opportunities in the global infectious disease rapid diagnostics testing market? • What are the underlying structures resulting in the emerging trends within the infectious disease diagnostic assays and systems? • What was the market value of the leading segments of the global infectious disease rapid diagnostics

Johnson & Johnson

Cue Health closes $100M to validate its connected molecular testing platform | MobiHealthNews | 6/10/2020

The Cue Health Monitoring System can deliver its results through a smartphone dashboard, and is intended for use by health professionals and consumers alike. 11:51 am Share Cue Health, a rapid diagnostics startup now working on a connected testing device, has closed $100 million in a Series C round announced this morning. Decheng Capital, Foresite Capital, Madrone Capital Partners, Johnson & Johnson Innovation, ACME Capital and other unnamed investment firms all …

Roche Diagnostics

Global Sepsis Diagnostics Market 2020-2025 - Evolution of Novel Biomarkers for Spesis Diagnosis Present Lucrative Opportunities | PR Newswire | 5/27/2020

… clinical benefits of diagnostic products in risk assessment for infectious diseases. Some of the prominent players in the sepsis diagnostics market are bioMerieux ( France ), Becton Dickinson Company (US), Danaher (US), Abbott Laboratories (US), Roche Diagnostics ( Switzerland ), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), EKF Diagnostics (UK), Immunexpress ( Australia ), Response Biomedical ( Canada ), Axis-Shield Diagnostics (UK), and CytoSorbents (US). Key Topics Covered 1 Introduction 2 Research Methodology …

Qiagen

Quidel’s Lyra® Direct SARS-CoV-2 Assay Receives Emergency Use Authorization and CE Mark for Molecular Detection of COVID-19, Without Extraction Step | Business Wire | 5/19/2020

… in processing time. The assay retains its versatility in that it is capable of running on any of seven possible thermocyclers (Applied Biosystems 7500 Standard®, Applied Biosystems 7500 Fast®, Bio-Rad CFX96 Touch®, Qiagen Rotor-Gene Q®, Roche LightCycler® 480, Roche Cobas® z480, and Thermo Fisher QuantStudio 7 Pro®). 1 Lyra® Direct Receives CE Mark Separately, the Lyra® Direct SARS-CoV-2 Assay received CE Mark on May 8, 2020 …

Siemens Healthineers

Sepsis Diagnostics - Global Markets by Assay Technology, 2024 | PR Newswire | 11/26/2019

… Dx Curetis N.V. / Curetis GmbH Cytovale EKF Diagnostics Holdings GeneFluidics GenMark Dx Grifols Immunexpress Inflammatix Linear Diagnostics Luminex Corp Mbio Diagnostics Mobidiag Nanomix Qiagen Gmbh Response Biomedical Roche Molecular Diagnostics SeLux Diagnostics Septec Siemens Healthineers Sphingotec T2 Biosystems Thermo Fisher Scientific Inc 7. Sepsis Diagnostic Markets 7.1 Sepsis Diagnostics - Global Market Overview by Country 8. Global Sepsis Diagnostics Markets - By Assay Type 8.1 Global Market by Diagnostic Type - Overview 8.2 …

T2 Biosystems

T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel Nasdaq:TTOO | Globe Newswire | 11/20/2019

LEXINGTON, Mass., T2 Biosystems, Inc. (NASDAQ: TTOO ), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, and CARB-X, a global non-profit partnership dedicated to … hours. “Fighting antimicrobial resistance not only requires the development of rapid diagnostics, like the T2Resistance Panel, but also requires access to these innovations so they can make a positive impact on as many patients as …

GE Healthcare

Polymerase Chain Reaction (PCR) Global Market - Forecast to 2025 | PR Newswire | 11/7/2019

… of the major players in the PCR market are ThermoFisher Scientific, Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Becton, Dickinson and Company (U.S.), BioMerieux SA ( France ), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.S.), Hoffmann la Roche ( Switzerland ), Merck KGaA ( Germany ), Promega Corporation (U.S.), Qiagen N.V. ( Netherlands ) and Takara Bio , Inc.( Japan ). The report provides an in-depth market analysis of the above-mentioned segments across the following …

Alere

Director, Validation & Risk Management - Springfield, IL, , USA #jobs #Springfield pls RT | 11/6/2019

Job Detail for Director, Validation & Risk Management Job Location: Alere, Springfield, IL, , USA Job Detail for Director, Validation & Risk Management Job Location: Alere, Springfield, IL, , USA Jobs In Director Validation Risk Mana… Jobs In Director … opportunity for a Director, Validation & Risk Management within our Abbott Rapid Diagnostics business located at Lake Forest, IL. In this role, you will be the leader for planning, implementing and standardizing validation and calibration program …

Bristol-Myers

Top Stock Reports for Home Depot, Abbott & Bristol-Myers | Nasdaq | 8/22/2019

Top Stock Reports for Home Depot, Abbott & Bristol-Myers August 21, 2019, 02:04:00 PM EDT By Mark Vickery, Zacks.com Shutterstock photo Wednesday, August 21, 2019 The Zacks Research Daily presents the best research output of … This apart, synergies from Alere consolidation in the form of Rapid Diagnostics have been driving growth. Within Structural Heart, worldwide uptake of MitraClip therapy improves further. Meanwhile, the company’s emerging market performance has been promising …

NuVasive

Abbott’s Libre Adoption a Positive, Rhythm Management a Woe | Yahoo News | 8/22/2019

… reimbursement for this new indication has been initiated. This apart, synergies from Alere consolidation in the form of revenues from Rapid Diagnostics are extending the company’s business. Meanwhile, the emerging market performance has been extremely … the broader medical space are Medtronic MDT, Baxter BAX and NuVasive NUVA, each carrying the same top Zacks Rank as Abbott. You can see the complete list of today’s Zacks 1 Rank (Strong Buy) stocks …

Novartis

Top Research Reports for Abbott, Netflix & Philip Morris - Nasdaq.com | 7/19/2019

… the limelight within Diabetic Care on growth with FreeStyle Libre. This apart, synergies from Alere consolidation in the form of Rapid Diagnostics have been driving growth. Within Structural Heart, worldwide uptake of MitraClip therapy improves … featuring today include Bristol-Myers (BMY), United Technologies (UTX) and Novartis (NVS). Looking for Stocks with Skyrocketing Upside? Zacks has just released a Special Report on the booming investment opportunities of legal marijuana. Ignited by …

Siemens

Global Anti-Thrombin III Testing Market Outlook to 2023: Leading Players are Abbott Labs, Danaher Corp, Roche, Siemens Healthcare, and Thermo Fisher Scientific | Markets Insider | Business Insider | 7/16/2019

… GLOBE NEWSWIRE) – The “Global Anti-Thrombin III Testing Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The shift toward rapid diagnostics All anti-thrombin III testing products support rapid diagnostic tests (RDTs). RDTs are … include: Abbott Laboratories Danaher Corp. F. Hoffmann-La Roche Ltd. Siemens Healthcare GmbH Thermo Fisher Scientific Inc. Also, the anti-thrombin III testing market analysis report includes information on upcoming trends and challenges that will …

Siemens Healthcare

Global Anti-Thrombin III Testing Market Outlook to 2023: Leading Players are Abbott Labs, Danaher Corp, Roche, Siemens Healthcare, and Thermo Fisher Scientific | Globe Newswire | 7/16/2019

July 16, 2019 03:24 ET Source: Research and Markets Dublin, July 16, 2019 (GLOBE NEWSWIRE) – The “Global Anti-Thrombin III Testing Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The shift toward rapid diagnostics All anti-thrombin III testing products support rapid diagnostic tests (RDTs). RDTs are gaining popularity as they are easy to use and can screen biological samples quickly to provide results in no time. They are …

Abbott Labs

Global Anti-Thrombin III Testing Market Outlook to 2023: Leading Players are Abbott Labs, Danaher Corp, Roche, Siemens Healthcare, and Thermo Fisher Scientific | Globe Newswire | 7/16/2019

July 16, 2019 03:24 ET Source: Research and Markets Dublin, July 16, 2019 (GLOBE NEWSWIRE) – The “Global Anti-Thrombin III Testing Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The shift toward rapid diagnostics All anti-thrombin III testing products support rapid diagnostic tests (RDTs). RDTs are gaining popularity as they are easy to use and can screen biological samples quickly to provide results in no time. They are …

Cerner

Abbott (ABT) Grows on EPD Amid Rhythm Management Challenges - Nasdaq.com | 6/4/2019

Rapid Diagnostics are boosting the company’s business. Meanwhile, the emerging market performance has been extremely promising on several strategic developments. Meanwhile, a sluggish Rhythm Management arm in the United States persistently impedes growth. Also, increasing currency headwinds to some extent dented Abbott’s global performance in the las t report ed quarter. Key Picks Some Cerner (Buy). You can see Today’s Best Stocks from Zacks Would you like to see the …

Wellcome Trust

Wellcome Trust urges firms to donate £6bn for Covid-19 research | Business | The Guardian | 4/7/2020

It is ‘the best investment your business can make’, says medical research charity. The Wellcome Trust is calling on big businesses to donate $8bn (£6.4bn) for research into developing diagnostic tests, therapies and vaccines to … as director of the Wellcome Trust, said: “Drugs, vaccines and rapid diagnostics are the only way we have of saving lives, bringing this pandemic to an end and preventing it reappearing. This is the only …

Global Health Fund Calls for $8 Billion to Begin COVID-19 Exit Strategy | U.S. News & World Report | 4/7/2020

… and governments to provide $8 billion to support development and production of COVID-19 tests, drugs and vaccines. British-based Wellcome Trust said the initiative, dubbed COVID-Zero, is aimed at the private sector and … and, ultimately, the people who need them. “Drugs, vaccines and rapid diagnostics are the only way we have of saving lives, bringing this pandemic to an end and preventing it reappearing,” Farrar said. “This is …

Bill & Melinda Gates Foundation

Gates, Wellcome and Mastercard launch $125 million fund to finance COVID-19 treatments | TechCrunch | 3/10/2020

Jonathan Shieber @jshieber / 15 hours The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced a new initiative yesterday to accelerate technologies designed to identify, assess, develop and scale treatments to the COVID-19 epidemic. The … for which we must propel international partnerships to develop treatments, rapid diagnostics, and vaccines. Science is moving at a phenomenal pace against COVID-19, but to get ahead of this epidemic we need greater investment …

Gates, Wellcome and Mastercard launch $125 million fund to finance COVID-19 treatments | Yahoo News | 3/10/2020

… to fight climate change as part of a coalition led by Bill Gates. (AP Photo/Mark Lennihan, File) More The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced a new initiative yesterday to accelerate technologies … for which we must propel international partnerships to develop treatments, rapid diagnostics, and vaccines. Science is moving at a phenomenal pace against COVID-19, but to get ahead of this epidemic we need greater investment …

Morgan Stanley

Abbott Laboratories (NYSE:ABT) Downgraded to “Hold” at Zacks Investment Research - TheOlympiaReport | 8/25/2019

… the limelight within Diabetic Care on growth with FreeStyle Libre. This apart, synergies from Alere consolidation in the form of Rapid Diagnostics have been driving growth. Within Structural Heart, worldwide uptake of MitraClip therapy improves … of other research analysts have also weighed in on ABT. Morgan Stanley raised their price target on shares of Abbott Laboratories from $85.00 to $93.00 and gave the company an overweight rating in a research …

Abbott Laboratories (NYSE:ABT) Lowered to Hold at Zacks Investment Research - Ticker Report | 8/24/2019

… the limelight within Diabetic Care on growth with FreeStyle Libre. This apart, synergies from Alere consolidation in the form of Rapid Diagnostics have been driving growth. Within Structural Heart, worldwide uptake of MitraClip therapy improves … has been the topic of a number of other reports. Morgan Stanley raised their price target on Abbott Laboratories from $85.00 to $93.00 and gave the company an overweight rating in a report on Tuesday …

Melinda Gates

Gates, Wellcome and Mastercard launch $125 million fund to finance COVID-19 treatments | TechCrunch | 3/10/2020

Jonathan Shieber @jshieber / 15 hours The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced a new initiative yesterday to accelerate technologies designed to identify, assess, develop and scale treatments to the COVID-19 epidemic. The … for which we must propel international partnerships to develop treatments, rapid diagnostics, and vaccines. Science is moving at a phenomenal pace against COVID-19, but to get ahead of this epidemic we need greater investment …

Gates, Wellcome and Mastercard launch $125 million fund to finance COVID-19 treatments | Yahoo News | 3/10/2020

… fight climate change as part of a coalition led by Bill Gates. (AP Photo/Mark Lennihan, File) More The Bill & Melinda Gates Foundation, Wellcome and Mastercard announced a new initiative yesterday to accelerate technologies designed … for which we must propel international partnerships to develop treatments, rapid diagnostics, and vaccines. Science is moving at a phenomenal pace against COVID-19, but to get ahead of this epidemic we need greater investment …

John McDonough

T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel Nasdaq:TTOO | Globe Newswire | 11/20/2019

… rapid diagnostics, like the T2Resistance Panel, but also requires access to these innovations so they can make a positive impact on as many patients as possible,” said John McDonough, chairman and chief executive officer of T2 Biosystems. “We are grateful that with the invaluable help of CARB-X’s funding, patients in Europe can start benefitting clinically from the early detection of antibiotic-resistant bloodstream infections.” To receive CARB-X funding …

T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts Nasdaq:TTOO | Globe Newswire | 6/28/2019

… comes on the heels of several recent updates announced by the Company regarding expanding capabilities of its portfolio of groundbreaking rapid diagnostics and technology. This includes presentations at the Biodefense World Summit 2019 and the … one of the most common, costly and deadly illnesses,” said John McDonough, president and chief executive officer of T2 Biosystems. “Our technology serves as that very solution due to its ability to more rapidly identify …

Kevin Outterson

T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel Nasdaq:TTOO | Globe Newswire | 11/20/2019

… resistance markers directly from whole blood—in three to five hours. “Fighting antimicrobial resistance not only requires the development of rapid diagnostics, like the T2Resistance Panel, but also requires access to these innovations so they … from around the world to address drug-resistant bacteria,” said Kevin Outterson, Executive Director of CARB-X, which is based at the Boston University School of Law. “This represents a huge step forward for patients …

SutroVax Receives CARB-X Award for Up to $15 Million to Develop a Universal Vaccine to Prevent Group A Streptococcus Infections | PR Newswire | 9/3/2019

… and reduce the need for antibiotics, thereby helping to curb the spread of drug-resistance and enhancing health security,” said Kevin Outterson , Executive Director of CARB-X and Professor of Law at Boston University . “Thanks … 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human …

Laura Wood

Anti-Thrombin III Testing Market (2019-2023) Set to Witness a CAGR of Approx 6% - The Shift Toward Rapid Diagnostics is a Key Driver - ResearchAndMarkets.com | Business Wire | 7/16/2019

DUBLIN- The “Global Anti-Thrombin III Testing Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The shift toward rapid diagnostics All anti-thrombin III testing products support rapid diagnostic tests (RDTs). RDTs are gaining … about this report visit https://www.researchandmarkets.com/r/3fi81j Contacts ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call …

$16.2Bn Cardiac Biomarkers Testing Market by 2025 - Rising Demand for Efficient & Rapid Diagnostics of Cardiovascular Diseases | PR Newswire | 7/13/2019

… major growth trends which are providing lucrative growth opportunities to the cardiac biomarker market. The rising demand for efficient and rapid diagnostics of cardiovascular diseases is the key contributing factor to sector growth. Alere triage … focused, comprehensive and tailored research. Media Contact: Research and Markets Laura Wood , Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 …

State of Maine

Production Specialist II (Nights) | 7/6/2020

Rapid Diagnostics is part of Client’s Diagnostics family of businesses, bringing together exceptional teams of experts and industry leading technologies to support diagnostic testing which provides important information for treatment and management of diseases and other conditions.The position of Production Specialist II is within our Infectious Disease Developed Markets business unit located at Scarborough, Maine. In this role you will perform the work required for the automated assembly of components …

Production Specialist II (Nights) | 7/1/2020

Rapid Diagnostics is part of Client’s Diagnostics family of businesses, bringing together exceptional teams of experts and industry leading technologies to support diagnostic testing which provides important information for treatment and management of diseases and other conditions.The position of Production Specialist II is within our Infectious Disease Developed Markets business unit located at Scarborough, Maine. In this role you will perform the work required for the automated assembly of components …

Portland, Oregon

Covid-19 Diagnostics Market to Generate $445.4 Million by the end of 2020: AMR | Globe Newswire | 6/12/2020

… across the globe, no cure has been found yet. June 12, 2020 09:53 ET Source: Allied Market Research multilang-release Portland, OR, June 12, 2020 (GLOBE NEWSWIRE) – According to the reportby Allied Market Research, the … in number of covid-19 patientsworldwide, surge in need of rapid diagnostics, and unavailability of particular medicine or vaccine drive the growth of the global covid-19 diagnostics market. However, lack of awareness in developing …

Covid-19 Diagnostics Market to Generate $445.4 Million by the end of 2020: AMR | Benzinga | 6/12/2020

Portland, OR, June 12, 2020 (GLOBE NEWSWIRE) – According to the reportby Allied Market Research, the global covid-19 diagnostics market garnered $7.1 million in the first quarter of 2020, and is estimated to generate $445.4 … in number of covid-19 patientsworldwide, surge in need of rapid diagnostics, and unavailability of particular medicine or vaccine drive the growth of the global covid-19 diagnostics market. However, lack of awareness in developing …